CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results
- PMID: 22852007
- PMCID: PMC3400917
- DOI: 10.5114/aoms.2012.29407
CA-125 concentration in serum and peritoneal fluid in patients with endometriosis - preliminary results
Abstract
Introduction: Cancer antigen 125 (CA-125), known as a biomarker for women genital tract malignancies, could be also useful in detecting and monitoring endometriosis. The aim of this study was to evaluate CA-125 in serum and peritoneal fluid (PF) as an indicator of endometriosis.
Material and methods: Fifty-six patients admitted to the First Department of Obstetrics and Gynaecology for diagnostic or therapeutic laparoscopy conducted for infertility, pelvic pain, suspected endometriosis or ovarian cysts entered the study. Those with laparoscopically confirmed endometriosis were assigned to group A, those without this condition to group B. Blood for CA-125 was taken prior to surgery, centrifuged and assayed in accordance with the manufacturer's instructions (VIDAS CA-125 II). Peritoneal fluid and an endometrial biopsy were taken during laparoscopy. Statistical comparisons were performed using Statistica 7.1.
Results: Group A consisted of 44 women with laparoscopically confirmed diagnosis; 15 patients served as a control group. The mean value of CA-125 concentration in the endometriosis group was 33.98 U/ml, vs. 9.3 U/ml in the control group. The mean value of CA-125 in peritoneal fluid was 1241.88 U/ml in the non-endometriosis group versus 2640.23 U/ml in the study group; both results were statistically significant (p < 0.05). There was a significant correlation between the stage of endometriosis and CA-125 plasma concentration (R = 0.5993, p < 0.001). Cancer antigen 125 concentration in serum was a moderate predictor to distinguish between patients with and without endometriosis (AUC 0.794; 95% CI 0.668-0.921; p = 0.001).
Conclusions: Cancer antigen 125 is a well-known biomarker for endometriosis and helpful in daily clinical practice when endometriosis is suspected. The cut-off value in serum suggesting endometriosis with 68% sensitivity is 11 U/ml. This value is normal range for Ca-125 concentration.
Keywords: endometriosis; infertility; laparoscopy; pelvic pain.
Figures
Similar articles
-
Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis.Sao Paulo Med J. 2006 Jul 6;124(4):223-7. doi: 10.1590/s1516-31802006000400010. Sao Paulo Med J. 2006. PMID: 17086305 Free PMC article.
-
Serum and peritoneal CA-125 levels as diagnostic test for endometriosis.Eur J Obstet Gynecol Reprod Biol. 1996 May;66(1):41-3. doi: 10.1016/0301-2115(95)02372-0. Eur J Obstet Gynecol Reprod Biol. 1996. PMID: 8735757
-
High concentrations of the CA-125, CA 19-9 and CA 15-3 in the peritoneal fluid between patients with and without endometriosis.Arch Gynecol Obstet. 2005 Jan;271(1):40-5. doi: 10.1007/s00404-004-0645-7. Epub 2004 Jul 9. Arch Gynecol Obstet. 2005. PMID: 15243756
-
Laboratory testing for endometriosis.Clin Chim Acta. 2004 Feb;340(1-2):41-56. doi: 10.1016/j.cccn.2003.10.021. Clin Chim Acta. 2004. PMID: 14734195 Review.
-
The Effect of Surgical Intervention of Endometriosis to CA-125 and Pain.Malays J Med Sci. 2020 Dec;27(6):7-14. doi: 10.21315/mjms2020.27.6.2. Epub 2020 Dec 29. Malays J Med Sci. 2020. PMID: 33447130 Free PMC article. Review.
Cited by
-
MicroRNAs Dysregulation as Potential Biomarkers for Early Diagnosis of Endometriosis.Biomedicines. 2022 Oct 13;10(10):2558. doi: 10.3390/biomedicines10102558. Biomedicines. 2022. PMID: 36289820 Free PMC article. Review.
-
Assessment of peritoneal microbial features and tumor marker levels as potential diagnostic tools for ovarian cancer.PLoS One. 2020 Jan 9;15(1):e0227707. doi: 10.1371/journal.pone.0227707. eCollection 2020. PLoS One. 2020. PMID: 31917801 Free PMC article.
-
MicroRNA let-7: A promising non-invasive biomarker for diagnosing and treating external genital endometriosis.Turk J Obstet Gynecol. 2021 Dec 24;18(4):291-297. doi: 10.4274/tjod.galenos.2021.07277. Turk J Obstet Gynecol. 2021. PMID: 34955008 Free PMC article.
-
Therapeutic Strategies for Ovarian Cancer in Point of HGF/c-MET Targeting.Medicina (Kaunas). 2022 May 11;58(5):649. doi: 10.3390/medicina58050649. Medicina (Kaunas). 2022. PMID: 35630066 Free PMC article. Review.
-
Risk factors associated with endometriosis among infertile Iranian women.Arch Med Sci. 2013 Jun 20;9(3):506-14. doi: 10.5114/aoms.2013.35420. Epub 2013 May 28. Arch Med Sci. 2013. PMID: 23847674 Free PMC article.
References
-
- Yin BW, Dnistrian A, Lloyd KO. Ovarian cancer antigen CA-125 is encoded by the MUC16 mucin gene. Int J Cancer. 2002;98:737–40. - PubMed
-
- Nowak-Markwitz E, Michalak M, Spaczyński M. Prediction value of serum Ca 125 level in benefit secondary cytoreduction in advanced ovarian cancer patients. Współcz Onkol. 2003;7:662–7.
-
- Berek JS, Taylor PT, Nicodemus CF. CA-125 velocity at relapse is a highly significant predictor of survival post relapse: results of a 5-year follow-up survey to a randomized placebo-controlled study of maintenance oregovomab immunotherapy in advanced ovarian cancer. J Immunother. 2008;31:207–14. - PubMed
-
- Muyldermans M, Cornillie FJ, Koninckx PR. CA-125 and endometriosis. Hum Reprod Update. 1995;1:173–87. - PubMed
-
- Wilczak M, Rzymski P, Stryjakowska K, Stanek R, Opala T. Highly elevated levels of the antigen Ca-125 associated with inflammatory abdominal masses. Arch Med Sci. 2007;3:278–80.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous